Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897

PURPOSE: Myeloperoxidase (MPO) generates reactive oxygen species and also activates xenobiotics. In a rigorous clinical trial (Southwest Oncology Group SWOG-8897), we examined relationships between genotypes and disease-free survival (DFS) among women treated for breast cancer, as well as those who...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Ambrosone, Christine B., Barlow, William E., Reynolds, Wanda, Livingston, Robert B., Yeh, I-Tien, Choi, Ji-Yeob, Davis, Warren, Rae, James M., Tang, Li, Hutchins, Laura R., Ravdin, Peter M., Martino, Silvana, Osborne, C. Kent, Lyss, Alan P., Hayes, Daniel F., Albain, Kathy S.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Clinical Oncology 2009
الموضوعات:
Original Reports
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2799053/
https://ncbi.nlm.nih.gov/pubmed/19752340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8669
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة